Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Assis

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Seminars in Liver Disease|May 6, 2021
Role of Biliary Organoids in Cholestasis Research and Regenerative MedicineCarol J Soroka, Scott J Roberts, James L Boyer, et al.
Digestive Diseases and Sciences|July 31, 2025
Determining Best Practices and Content for Foundational Ambulatory GI and Hepatology Teaching During GI FellowshipAmy G Ogurick, Kay Chen, Zain Sobani, et al.
Digestive Diseases and Sciences|October 4, 2016
A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese PatientsDavid N Assis, Hiroki Takahashi, Lin Leng, et al.
Hepatology (Baltimore, Md.)|May 25, 2022
Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitisClaire Harrington, Swathi Krishnan, Cara L Mack, et al.
Hepatology Communications|December 19, 2024
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progressColleen M Hayes, Gina M Gallucci, James L Boyer, et al.
Alimentary Pharmacology & Therapeutics|February 18, 2026
Long-Term Use of Fenofibrate as Second-Line Therapy in Primary Biliary Cholangitis: A Retrospective StudyMariko Maxwell, Yanhong Deng, Bonnie Chen, et al.
Human Pathology|July 25, 2018
Histologic features of autoimmune hepatitis: a critical appraisalAnanta Gurung, David N Assis, Thomas R McCarty, et al.
Inflammation|July 15, 2022
Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary CholangitisGina M Gallucci, Bader Alsuwayt, Adam M Auclair, et al.
Cells|August 9, 2024
PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver DiseasesGina M Gallucci, Colleen M Hayes, James L Boyer, et al.
Hepatology Communications|September 24, 2021
Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With CholestasisGina M Gallucci, Jocelyn Trottier, Christopher Hemme, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Seminars in Liver Disease|May 6, 2021
Role of Biliary Organoids in Cholestasis Research and Regenerative MedicineCarol J Soroka, Scott J Roberts, James L Boyer, et al.
Digestive Diseases and Sciences|July 31, 2025
Determining Best Practices and Content for Foundational Ambulatory GI and Hepatology Teaching During GI FellowshipAmy G Ogurick, Kay Chen, Zain Sobani, et al.
Digestive Diseases and Sciences|October 4, 2016
A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese PatientsDavid N Assis, Hiroki Takahashi, Lin Leng, et al.
Hepatology (Baltimore, Md.)|May 25, 2022
Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitisClaire Harrington, Swathi Krishnan, Cara L Mack, et al.
Hepatology Communications|December 19, 2024
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progressColleen M Hayes, Gina M Gallucci, James L Boyer, et al.
Alimentary Pharmacology & Therapeutics|February 18, 2026
Long-Term Use of Fenofibrate as Second-Line Therapy in Primary Biliary Cholangitis: A Retrospective StudyMariko Maxwell, Yanhong Deng, Bonnie Chen, et al.
Human Pathology|July 25, 2018
Histologic features of autoimmune hepatitis: a critical appraisalAnanta Gurung, David N Assis, Thomas R McCarty, et al.
Inflammation|July 15, 2022
Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary CholangitisGina M Gallucci, Bader Alsuwayt, Adam M Auclair, et al.
Cells|August 9, 2024
PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver DiseasesGina M Gallucci, Colleen M Hayes, James L Boyer, et al.
Hepatology Communications|September 24, 2021
Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With CholestasisGina M Gallucci, Jocelyn Trottier, Christopher Hemme, et al.
Pageof 6